Cleanscion

Virus checks on mother plants for citrus and banana nurseries before they sell

Rural SMEs

TL;DR Cleanscion tests the mother plants and lab cultures that nurseries multiply from, using quick colour-change DNA tests, so a virus gets caught before it's copied into thousands of saplings. Nurseries and tissue-culture labs pay per season. It works because one infected parent plant can seed a whole district's orchards.

The problem

Most fruit plants in India are bought as saplings, and a sapling carries whatever its parent carried. In three Kinnow orchards in north-west India, researchers found one virus in 48 of 63 leaf samples and a second in 18[1]. Both cut flowering, fruit size and yield, and neither shows clearly in a young plant.

Banana has the same weak spot at a bigger scale. Scientists at the national banana research centre report that tissue-culture plants are more prone to bunchy top virus than suckers[2], and tissue culture is how commercial growers plant now. Lab indexing exists but the older biological method is slow and costly[1], so a good chunk of nurseries skip it and sell on trust.

The idea

What it does: diagnostic testing of planting material only. Cleanscion tests and reports. It does not certify plants, which stays with government certification schemes, and it sells no pesticides or plants.

Here's how it works. A field team visits each client nursery or tissue-culture lab before the propagation season and samples every mother plant or culture line. The samples go into closed-tube isothermal (LAMP) tests that change colour when viral DNA is present, and the published versions for bunchy top and bract mosaic viruses in banana need nothing more than a heat block[3][4]. A partner lab confirms positives by PCR. The nursery gets a plant-by-plant report it can show buyers, plus a list of plants to destroy.

The seed pitched plants that glow when they're sick. Engineered sentinel plants are still research and would need genetic-modification approval before going near a field, so I kept the early-warning goal and swapped in tests that already work.

Who pays

The nursery owner or tissue-culture lab pays, because they lose the most when a batch dies in a customer's field. The real pressure point is the big buyer - state horticulture departments, FPOs and contract growers. If they ask for a test report then nurseries will pay for one. I couldn't find a public price for plant virus testing in India, so your first job is to find out what a nursery will pay per mother plant.

Why now

Colour-read isothermal tests have moved from papers into practice over the last few years. Indian groups published colour-change assays for banana viruses in 2022 and 2023[3][4], and a duplex test for two Kinnow viruses followed in 2024[1]. The kit now costs less than the reputational hit of one failed orchard.

Market signal

There's no public figure for spending on plant virus testing in India. The narrow signal is the infection rate itself, where 76% of sampled Kinnow plants carried one virus[1]. Adjacent - one US firm has sold plant pathogen test kits and testing services since 1981[5], which tells you a specialist plant-diagnostics business can last.

Who's already doing this

ICAR institutes and agricultural universities index plants, but they're research bodies with queues and not a service that turns up before the season. That US firm sells kits and lab testing worldwide[5] but has no Indian field service. I found no Indian private firm selling nursery virus testing on a seasonal contract. That's the gap, a fast and local service built around the nursery.

How hard is it?

Difficulty Moderate (42/100)
Starting capital ₹60 L–1.1 Cr
Time to launch 6–9 months

The tests are published, but turning them into reliable kits for each crop and virus takes careful validation. Sales is the harder bit. Nurseries are small, scattered and watch every rupee, and plenty of them would honestly rather not know their stock is infected. You need buyers to demand the reports.

Licences and approvals

No sector licence is needed to test plants, but you must stay out of certification.

  • Planting-material certification stays with government schemes. Call your reports test results, never certificates, from day one. Whether a private lab can become an accredited test lab is [Requires validation].
  • NABL accreditation (ISO/IEC 17025) from NABL, before you scale, so buyers trust your reports.
  • Biosafety practice for plant pathogens, before your first sample, with samples destroyed after testing.
  • Baseline: company or LLP registration with the MCA, GST once over the threshold, your state's Shops and Establishments Act, and the DPDP Act for client data.

Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.

How AI can power this business

  • Sample tracking. Photo-log every sampled mother plant with its tag and GPS point, so a positive result maps straight to the right plant.
  • Result reading. A phone camera can read the LAMP colour change and log it, which cuts transcription errors on busy days.
  • Season planning. Use past results by nursery, crop and region to decide where to sample first before propagation starts.
  • Buyer-ready reports. Draft the plant-by-plant report and destroy list automatically from the lab sheet.

Don't trust AI to call a plant clean from a leaf photo. Only the test and the PCR confirmation decide that.

Want to work out the AI layer for Cleanscion? Talk to Yash →

Biggest risks

  • Nurseries don't want bad news. A positive result means destroying stock, so some owners will dodge testing unless their buyers insist on it.
  • False negatives. A missed infection that later shows up in an orchard would wreck trust in every report you've sent.
  • Seasonal cash flow. Demand bunches up before planting seasons and leaves the lab and field team sitting idle for months.

Our take

I think this suits a plant pathologist or molecular biologist who can also sell to nursery owners and horticulture officials. If you're after software margins then look elsewhere. Before you build a lab, prove one thing - that a state department, FPO or large grower will make test reports a condition of purchase.

Questions founders ask

Plan for roughly ₹60 L–1.1 Cr for the lab, field team and early operating costs.

Do I need a licence to start a plant virus testing business in India?

No sector licence, but only government schemes certify plants. Sell test results, aim for NABL accreditation and follow biosafety practice.

Can I start a nursery virus testing service in another country?

Yes, wherever nurseries sell citrus or banana planting material. Check who is allowed to certify plants there.

Download the kit

The free Cleanscion validation kit has the line-by-line capital breakdown, the effort scoring, the rules checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for nurseries and plant buyers, and 5 assumptions to test. Download the kit →

Talk to Yash

Thinking about building Cleanscion or something close to it? The make-or-break work is getting plant buyers to insist on test reports, so nurseries have a reason to pay, and that's the kind of thing I help founders work out. If you need a hand, you know where to find me. Talk to Yash →

Sources

  1. Kumar et al., "Mixed infection of two mandariviruses in Kinnow mandarin and duplex RT-PCR detection", 3 Biotech, 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11143089/
  2. ICAR-NRCB authors, "Virus titre determines the efficiency of Pentalonia nigronervosa to transmit banana bunchy top virus", Virusdisease, 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC6261897/
  3. Nahla Binth et al., "Colorimetric LAMP detection platform for banana bunchy top virus", Virusdisease, 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9481777/
  4. Madhu Kovileri et al., "RT-LAMP for colorimetric detection of banana bract mosaic virus", 3 Biotech, 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10102263/
  5. Agdia, official site, accessed 2026-10-21. https://www.agdia.com/

For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.

Reviews

No reviews yet